Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.In the 7MM, the 12-month total prevalent cases of migraine are expected to increase from 74,226,117 cases in ...

Striking brain similarities have been detected in patients who experience long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), in particular, a larger than normal hippocampus.

As the cooler weather settles in, you might notice more headaches or even migraines sneaking up on you. If you’ve wondered ...

Frequent headaches just do not mean you are tired or sitting too much in front of the screens. According to experts, frequent head or face pain can indicate a few serious health issues like high blood ...

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke.

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

Fibromyalgia is a common chronic pain condition that affects mostly women ... Zembrace and Tosymra are not used to prevent migraines. It is not known if Zembrace or Tosymra are safe and effective in ...

With historical data showing migraine to be underdiagnosed and undertreated, new guidance from the American College of ...

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.

Paul Howe, chief commercial officer at Protega Pharma, discusses recent rule changes and how the industry is impacted by them ...